New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics
| dc.contributor.editor | Felgueiras, Helena | |
| dc.date.accessioned | 2022-08-12T12:49:06Z | |
| dc.date.available | 2022-08-12T12:49:06Z | |
| dc.date.issued | 2022 | |
| dc.identifier | ONIX_20220812_9783036547367_67 | |
| dc.identifier.uri | https://directory.doabooks.org/handle/20.500.12854/91188 | |
| dc.description.abstract | New approaches to deal with the growing concern associated with antibiotic-resistant bacteria are in great demand. For many years, antibiotics have widely been employed to treat infections. However, their excessive consumption and misuse have accelerated the rise of antibiotic-resistant microorganisms, which constitute a major challenge to global health. The antibiotic crisis is now a general concern; therefore, alternative biomolecules or drug delivery systems to treat infections are urgently needed. From natural extracts to traditional medicine remedies, to newly engineered nanocapsules and nanoparticles, to bio-based, biodegradable delivery platforms, many systems to fight infections are explored in this book. | |
| dc.language | English | |
| dc.subject.classification | thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general | en_US |
| dc.subject.classification | thema EDItEUR::P Mathematics and Science::PN Chemistry | en_US |
| dc.subject.other | nanoparticles | |
| dc.subject.other | 4-Nerolidylcatechol | |
| dc.subject.other | antifungals | |
| dc.subject.other | Microsporum canis | |
| dc.subject.other | polycaprolactone | |
| dc.subject.other | nanoprecipitation | |
| dc.subject.other | silver nanoparticles | |
| dc.subject.other | green synthesis method | |
| dc.subject.other | Catharanthus roseus | |
| dc.subject.other | Azadirachta indica | |
| dc.subject.other | multidrug-resistant bacteria | |
| dc.subject.other | wound healing | |
| dc.subject.other | nosocomial infection | |
| dc.subject.other | plant extract | |
| dc.subject.other | grapefruit seed extract | |
| dc.subject.other | antibacterial activity | |
| dc.subject.other | fiber–hydrogel composite | |
| dc.subject.other | biodegradable polymers | |
| dc.subject.other | skin regeneration | |
| dc.subject.other | drug delivery platforms | |
| dc.subject.other | controlled release | |
| dc.subject.other | tetramycin | |
| dc.subject.other | antimicrobial activity | |
| dc.subject.other | kiwifruit disease | |
| dc.subject.other | conventional antibiotics | |
| dc.subject.other | storage quality | |
| dc.subject.other | gold nanoparticles | |
| dc.subject.other | flavonoids | |
| dc.subject.other | Gram-negative bacteria | |
| dc.subject.other | DNA gyrase | |
| dc.subject.other | in silico | |
| dc.subject.other | multidrug-resistant Acinetobacter baumannii (MDR-AB) | |
| dc.subject.other | hypertonic saline | |
| dc.subject.other | antibiotics | |
| dc.subject.other | biofilm | |
| dc.subject.other | aerosol delivery | |
| dc.subject.other | ultrahigh-throughput screening | |
| dc.subject.other | live biosensors | |
| dc.subject.other | antibiotic discovery | |
| dc.subject.other | gram-negative pathogens | |
| dc.subject.other | microfluidic droplet cocultivation | |
| dc.subject.other | efficient promoters | |
| dc.subject.other | polymyxins | |
| dc.subject.other | colistin biosynthetic gene cluster | |
| dc.subject.other | single cell | |
| dc.subject.other | multi-omics | |
| dc.subject.other | quercetin | |
| dc.subject.other | magnesium-doped calcium silicate | |
| dc.subject.other | osteogenic activity | |
| dc.subject.other | bone regeneration and nanofiber scaffold | |
| dc.subject.other | bulk-tank milk | |
| dc.subject.other | mastitis | |
| dc.subject.other | methicillin | |
| dc.subject.other | milk | |
| dc.subject.other | goat | |
| dc.subject.other | somatic cell counts | |
| dc.subject.other | staphylococcus | |
| dc.subject.other | tetracycline | |
| dc.subject.other | total bacterial counts | |
| dc.subject.other | prosthetic joint infection | |
| dc.subject.other | local prevention | |
| dc.subject.other | allicin | |
| dc.subject.other | chitosan | |
| dc.subject.other | Sphaerotheca sp. | |
| dc.subject.other | antibiotic | |
| dc.subject.other | Rosa roxburghii | |
| dc.subject.other | cyclic diphenylphosphonate | |
| dc.subject.other | quinoline | |
| dc.subject.other | DNA gyrase inhibitor | |
| dc.subject.other | molecular docking | |
| dc.subject.other | magnesium ion | |
| dc.subject.other | n/a | |
| dc.title | New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics | |
| dc.type | book | |
| oapen.identifier.doi | 10.3390/books978-3-0365-4735-0 | |
| oapen.relation.isPublishedBy | 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 | |
| oapen.relation.isbn | 9783036547367 | |
| oapen.relation.isbn | 9783036547350 | |
| oapen.pages | 232 | |
| oapen.place.publication | Basel |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||

